Systemic Steroids in Caustic Ingestion: Not Recommended
Systemic corticosteroids are NOT indicated for preventing esophageal stricture formation after caustic ingestion, as high-quality evidence demonstrates no benefit in stricture prevention. 1, 2
Evidence Against Systemic Steroids
The most robust evidence comes from a 2018 systematic review and meta-analysis of randomized controlled trials, which found no benefit of corticosteroids in preventing esophageal strictures (RR = 0.63,95% CI = 0.29-1.37) 1. This is corroborated by an 18-year prospective randomized controlled trial in 60 children showing strictures developed in 10/31 steroid-treated patients versus 11/29 controls (not significant), with no difference in esophageal replacement rates 2.
The development of esophageal stricture relates only to the severity of the initial corrosive injury, not steroid use 2.
When Steroids ARE Indicated: Refractory Strictures Only
The only evidence-based role for steroids in caustic injury is intralesional steroid injection for established refractory strictures during endoscopic dilatation:
- Use intralesional triamcinolone (0.5 mL aliquots of 40 mg/mL to four quadrants) combined with dilatation in refractory strictures showing evidence of inflammation after maximizing anti-reflux therapy 3
- This is for strictures that fail to maintain ≥14 mm luminal diameter after five sequential dilatations 1-2 weeks apart 3
- Inject with 23-gauge needle, leaving in place ≥1 minute to minimize leakage 3
Acute Management Algorithm
Initial Assessment (First 12-48 Hours)
- Perform upper GI endoscopy within 12-48 hours to determine prognosis and guide management 3
- Use gentle air insufflation or preferably CO₂ 3
- Contraindications to endoscopy: radiological perforation or supraglottic/epiglottic burns 3
- CT with contrast is preferred over endoscopy when available, as it better predicts transmural necrosis 4
Endoscopic Grading Determines Outcome
- Grade I-IIa injuries: low stricture risk
- Grade IIb-III injuries: high stricture risk (up to 47% in severe cases) 5
- Stricture formation correlates with initial injury severity, not treatment modality 2
Stricture Management (If It Develops)
Timing of Dilatation
- Avoid dilatation within 3 weeks of initial ingestion (most hazardous period) 3
- Begin dilatation 3-6 weeks post-ingestion for short (<5 cm), few (<3) strictures 4
- Maintain interval between dilatations <2 weeks 3
Dilatation Technique
- Either bougie or balloon acceptable—no clear advantage 3
- Timely stricture management with dilatation is key to patient outcomes 3
- Perforation rates higher than standard strictures (0.4-32%, lower with experienced operators at 4.5%) 3
Critical Pitfalls to Avoid
- Do not give systemic steroids acutely to prevent strictures—this is ineffective and unsupported by evidence 1, 2
- Do not dilate between weeks 1-3 post-ingestion (highest perforation risk) 3
- Do not use intralesional steroids in acute phase—only for established refractory strictures with inflammation 3
- Ensure maximal PPI therapy before labeling stricture as refractory 3
Nuance in the Literature
While older pediatric case series suggested potential benefit from high-dose methylprednisolone 5, 6, these were uncontrolled observations. The highest quality evidence from randomized trials definitively shows no benefit 1, 2. The 2018 UK guidelines on esophageal dilatation mention oral steroids as a historical technique "with limited evidence on outcomes" but provide no recommendation for their use 3.